Source: Virtual Congress 2020 – Epidemiology of paediatric respiratory diseases
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Miteva (Sofia, Bulgaria), S. Parina (Sofia, Bulgaria), K. Guenkova (Sofia, Bulgaria), B. Georgieva (Sofia, Bulgaria), P. Perenovska (Sofia, Bulgaria), G. Petrova (Sofia, Bulgaria). Clinical features of Mycoplasma pneumoniae infections in Bulgarian children. 3109

Member's Comments

No comment yet.

Related content which might interest you: Clinical aspects of chlamydia pneumoniae pneumonia in adults Source: Eur Respir J 2004; 24: Suppl. 48, 642s Year: 2004 Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001 Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia Source: Eur Respir J 2011; 37: 1522-1524 Year: 2011 Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 The radiological findings of Mycoplasma pneumoniae pneumonia from our 43 patients Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005 Mycoplasma pneumoniae infections in a paediatric setting; changes in epidemiology and clinical presentation Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 Chlamidia pneumoniae and Mycoplasma pneumoniae infection of airways in patients with broncho-obstructive diseases Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005 Molecular characterisation and clinical presentation of Mycoplasma pneumoniae lower respiratory tract infections in children Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018 Chlamydia pneumoniae pneumonia and Mycoplasma pneumoniae pneumonia: comparison of clinical findings and CT findings Source: Eur Respir J 2004; 24: Suppl. 48, 488s Year: 2004 Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Chlamydia pneumoniae and mycoplasma pneumoniae seropositivities in children with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 849s Year: 2006 Clinical and radiological features can help predict Mycoplasma pneumoniae lower respiratory tract infection in children Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 Pneumonia caused by Mycoplasma pneumoniae Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005 Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia? Source: Eur Respir J 2003; 21: 741-742 Year: 2003 Clinical and epidemiologic characteristics of mycoplasma pneumoniae infections in Santiago, Chile Source: Eur Respir J 2002; 20: Suppl. 38, 337s Year: 2002 Influence of streptococcus pneumoniae serotypes in clinical outcomes of pneumonias Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Severe Chlamydia pneumoniae community-acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 545s Year: 2003 Clinical features of acute respiratory infections associated with Streptococcus milleri group in the elderly Source: Eur Respir J 2003; 22: Suppl. 45, 543s Year: 2003